AI Verdict
IRTC has stronger fundamentals based on our AI analysis.
ISCO vs IRTC Fundamental Comparison
| Metric | ISCO | IRTC |
|---|---|---|
| Revenue | $6.9M | $747.1M |
| Net Income | $-70,000.0 | $-44.6M |
| Net Margin | -1.0% | -6.0% |
| ROE | N/A | -29.2% |
| ROA | -1.3% | -4.4% |
| Current Ratio | 0.80x | 4.63x |
| Debt/Equity | N/A | 0.23x |
| EPS | $-0.01 | $-1.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ISCO vs IRTC: Frequently Asked Questions
Is ISCO or IRTC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IRTC has stronger fundamentals. ISCO is rated STRONG SELL (92% confidence) while IRTC is rated HOLD (62% confidence). This is not investment advice.
How does ISCO compare to IRTC fundamentally?
International Stem Cell CORP has ROE of N/A vs iRhythm Holdings, Inc.'s -29.2%. Net margins are -1.0% vs -6.0% respectively.
Which stock pays higher dividends, ISCO or IRTC?
ISCO has a dividend yield of N/A or no dividend while IRTC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ISCO or IRTC for long term?
For long-term investing, consider that ISCO has STRONG SELL rating with 92% confidence, while IRTC has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ISCO vs IRTC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ISCO vs IRTC, the AI consensus favors IRTC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.